The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Propagation and recovery of intact, infectious Epstein–Barr virus from prokaryotic to human cells
Open accessAbstract
With current techniques, genetic alterations of herpesviruses are difficult to perform, mostly because of the large size of their genomes. To solve this problem, we have designed a system that allows the cloning of any γ-herpesvirus in Escherichia coli onto an F factor-derived plasmid. Immortalized B cell lines were readily established with recombinant Epstein–Barr virus (EBV), demonstrating that the F factor-cloned EBV genome has all the characteristics of wild-type EBV. Because any genetic modification is possible in E. coli , this experimental approach opens the way to the genetic analysis of all EBV functions. Moreover, it is now feasible to generate attenuated EBV strains in vitro such that vaccine strains can be designed. Because we incorporated the genes for hygromycin resistance and green fluorescent protein onto the E. coli cloned EBV genome, the still open question of the EBV target cells other than B lymphocytes will be addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793
DNA sequence and expression of the B95-8 Epstein—Barr virus genome
Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C., Séguin, C., et al. (1984) · Nature · doi:10.1038/310207a0 · Cited by 2,053
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
Kaye, K. M., Izumi, K. M., & Kieff, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9150 · Cited by 762
CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA)
Pulvertaft, R. J. V. (1964) · The Lancet · doi:10.1016/s0140-6736(64)92345-1 · Cited by 626
Genetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytes
Hammerschmidt, W., & Sugden, B. (1989) · Nature · doi:10.1038/340393a0 · Cited by 541
Self-citationEpstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
Cohen, J. I., Wang, F., Mannick, J., & Kieff, E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9558 · Cited by 483
Kilger, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1700 · Cited by 483
Miller, G., Shope, T., Lisco, H., Stitt, D., & Lipman, M. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.2.383 · Cited by 440
Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome
Messerle, M., Crnkovic, I., Hammerschmidt, W., Ziegler, H., & Koszinowski, U. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14759 · Cited by 426
Self-citationTomkinson, B., Robertson, E., & Kieff, E. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.2014-2025.1993 · Cited by 388
Hammerschmidt, W., & Sugden, B. (1988) · Cell · doi:10.1016/0092-8674(88)90028-1 · Cited by 381
Self-citationPost, L. E., & Roizman, B. (1981) · Cell · doi:10.1016/0092-8674(81)90247-6 · Cited by 336
Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis
Gardella, T., Medveczky, P., Sairenji, T., & Mulder, C. (1984) · Journal of Virology · doi:10.1128/jvi.50.1.248-254.1984 · Cited by 250
Kempkes, B., Spitkovsky, D., Jansen-Dürr, P., Ellwart, J. W., Kremmer, E., Delecluse, H. J., Rottenberger, C., Bornkamm, G. W., & Hammerschmidt, W. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb06978.x · Cited by 247
Self-citationConstruction of Large DNA Segments in Escherichia coli
O'Connor, M., Peifer, M., & Bender, W. (1989) · Science · doi:10.1126/science.2660262 · Cited by 201
Mocarski, E. S., Post, L. E., & Roizman, B. (1980) · Cell · doi:10.1016/0092-8674(80)90172-5 · Cited by 186
Zimber‐Strobl, U., Kempkes, B., Marschall, G., Zeidler, R., van Kooten, C., Banchereau, J., Bornkamm, G. W., & Hammerschmidt, W. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01098.x · Cited by 114
Self-citationWang, S., & Vos, J. H. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8422-8430.1996 · Cited by 103
Epstein-Barr virus recombinants from overlapping cosmid fragments
Tomkinson, B. E., Robertson, E. S., Yalamanchili, R. R., Longnecker, R., & Kieff, E. D. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.7298-7306.1993 · Cited by 68
Immortalization of human primary B lymphocytes in vitro with DNA.
Kempkes, B., Pich, D., Zeidler, R., & Hammerschmidt, W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.13.5875 · Cited by 48
Self-citationGiordano, T. J., & McAllister, W. T. (1990) · Gene · doi:10.1016/0378-1119(90)90045-s · Cited by 27
Cited by
Latency and lytic replication in Epstein–Barr virus-associated oncogenesis
Münz, C. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0249-7 · Cited by 469
Feederle, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.3080 · Cited by 387
Borst, E.-M., Hahn, G., Koszinowski, U. H., & Messerle, M. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8320-8329.1999 · Cited by 384
Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
Kanekiyo, M., Bu, W., Joyce, M. G., Meng, G., Whittle, J. R. R., Baxa, U., Yamamoto, T., Narpala, S., Todd, J.-P., Rao, S. S., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.043 · Cited by 366
Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5
Barth, S., Pfuhl, T., Mamiani, A., Ehses, C., Roemer, K., Kremmer, E., Jaker, C., Hock, J., Meister, G., & Grasser, F. A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1080 · Cited by 351
Metadata
- Authors
- Delecluse, H.-J., Hilsendegen, T., Pich, D., Zeidler, R., & Hammerschmidt, W.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-07-07
- Volume
- 95
- Issue
- 14
- Pages
- 8245-8250
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2085161568
- Cited by
- 467
- References
- 21
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.